Decided

No. 11-204

Michael Shane Christopher, et al. v. SmithKline Beecham Corporation, dba GlaxoSmithKline

from the United States Court of Appeals for the Ninth Circuit

See other cases from the Ninth Circuit.

Docket Entries

JUDGMENT ISSUED.

Adjudged to be AFFIRMED Alito, J., delivered the opinion of the Court, in which Roberts, C. J., and Scalia, Kennedy, and Thomas, JJ., joined. Breyer, J., filed a dissenting opinion, in which Ginsburg, Sotomayor, and Kagan, JJ., joined. (orders list)

Letter from counsel for petitioners filed. (Distributed)

Letter from counsel for petitioners filed. (Distributed)

Argued. For petitioners: Thomas C. Goldstein, Washington, D. C.; and Malcolm L. Stewart, Deputy Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For respondent: Paul D. Clement, Washington D. C.

Reply of petitioners Michael Shane Christopher, et al. filed. (Distributed)

Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument GRANTED. (orders list)

Brief amicus curiae of Center for Constitutional Jurisprudence filed. (Distributed)

Brief amici curiae of Washington Legal Foundation, et al. filed. (Distributed)

Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed. (Distributed)

Brief amicus curiae of Equal Employment Advisory Council filed. (Distributed)

Brief amicus curiae of Equal Employment Advisory Council filed.

Brief amicus curiae of Chamber of Commerce of the United States of America filed. (Distributed)

Brief amicus curiae of National Federation of Independent Business Small Business Legal Center filed. (Distributed)

Brief of respondent SmithKline Beecham Corporation, dba GlaxoSmithKline filed. (Distributed)

Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed.

CIRCULATED.

Record received from U.S.C.A. for 9th Circuit. (1 envelope)

Record from U.S.D.C. for the District of Arizona is electronic.

Brief amici curiae of Certified Class of Pharmaceutical Representatives from Johnson & Johnson filed.

Brief amici curiae of Medical Professionals filed.

Brief amici curiae of Pharmaceutical Representatives filed.

Brief amicus curiae of the United States filed.

Brief amici curiae of National Employment Lawyers Association, et al. filed.

Brief amici curiae of National Employment Lawyers Association, et al. filed. (Distributed)

SET FOR ARGUMENT ON Monday, April 16, 2012

Joint appendix filed.

Joint appendix filed. (Statement of costs filed.)

Brief of petitioners Michael Shane Christopher, et al. filed.

Consent to the filing of amicus curiae briefs in support of either party party received from counsel for the petitioners.

Consent to the filing of amicus curiae briefs in support of either party or of neither party, received from counsel for the petitioners.

The time to file respondent's brief on the merits is extended to and including March 19, 2012.

The time to file the joint appendix and petitioners' brief on the merits is extended to and including January 30, 2012.

Petition GRANTED. (orders list)

DISTRIBUTED for Conference of November 22, 2011.

Brief of respondent SmithKline Beecham Corporation, dba GlaxoSmithKline filed.

Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.

Brief of respondent SmithKline Beecham Corporation, dba GlazoSmithKline in opposition filed.

Brief amicus curiae of Chamber of Commerce of the United States of America filed.

Brief of respondent SmithKline Beecham Corporation, dba GlazoSmithKline filed.

Order extending time to file response to petition to and including October 17, 2011.

Petition for a writ of certiorari filed. (Response due September 16, 2011)

Consent to the filing of amicus curiae briefs, in support of either party or of neither party , received from counsel for the petitioners

Parties

Michael Shane Christopher, et al., Petitioner, represented by Michael R. Pruitt

Michael Shane Christopher, et al., Petitioner, represented by Thomas C. Goldstein

SmithKline Beecham Corporation, dba GlaxoSmithKline, Respondent, represented by Paul D. Clement

SmithKline Beecham Corporation, dba GlaxoSmithKline, Respondent, represented by Neal D. Mollen

SmithKline Beecham Corporation, dba GlazoSmithKline, Respondent, represented by Neal D. Mollen

SmithKline Beecham Corporation, dba GlazoSmithKline, Respondent, represented by Paul D. Clement

Amici Curiae

Center for Constitutional Jurisprudence, Amicus Curiae, represented by John C. Eastman

Certified Class of Pharmaceutical Representatives from Johnson & Johnson, Amicus Curiae, represented by Aashish Y. Desai

Chamber of Commerce of the United States of America, Amicus Curiae, represented by Matthew W. Lampe

Equal Employment Advisory Council, Amicus Curiae, represented by Rae T. Vann

Medical Professionals, Amicus Curiae, represented by Sarah M. Shalf

Michael Shane Christopher, et al. v. SmithKline Beecham Corporation, dba GlaxoSmithKline, Amicus Curiae, represented by Malcolm L. Stewart

National Employment Lawyers Association, et al., Amicus Curiae, represented by Paul W. Mollica

National Federation of Independent Business Small Business Legal Center, Amicus Curiae, represented by Kevin Michael Kraham

Pharmaceutical Representatives, Amicus Curiae, represented by Michael R. DiChiara

Pharmaceutical Research and Manufacturers of America, Amicus Curiae, represented by Jeffrey S. Bucholtz

the United States, Amicus Curiae, represented by Donald B. Verrilli Jr.

Washington Legal Foundation, et al., Amicus Curiae, represented by Cory L. Andrews

 
Last updated: September 20, 2012